ArticleJournal of pharmaceutical analysis2024

Clinically and orally compatible formulation-manufactured DDX5 (p68)-targeting molecular glue FL118 products exhibit low toxicity but high efficacy against human cancer.

Xiang Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.